The role of increased prolactin levels under GnRH analogue treatment in advanced prostatic carcinoma. 1988

H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
Department of Urology, Ichilov Hospital, Tel-Aviv, Israel.

The role of prolactin in the progress of prostatic carcinoma still is obscure. It is known to modulate testosterone metabolism and may have a prognostic value in determining disease progression. Prolonged treatment with a GnRH analogue has been introduced recently as a therapeutic alternative to surgical castration in advanced prostatic carcinoma. It has been reported that prolactin levels remain unchanged or even decrease in GnRH analogue treatment. By contrast, in this series of 15 prostatic carcinoma patients treated with GnRH analogue, a significant rise was demonstrated in clinical responders as well as nonresponders. In the latter group, prolactin rise was more pronounced. These results suggest that frequent prolactin determinations might be of prognostic value in determining early disease progression under GnRH analogue treatment.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002064 Buserelin A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications. Bigonist,Buserelin Acetate,HOE-766,Profact,Receptal,Suprecur,Suprefact,Tiloryth,Acetate, Buserelin,HOE 766,HOE766
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
September 1988, Harefuah,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
September 1990, Urology,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
January 1987, Progress in clinical and biological research,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
September 1979, British medical journal,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
January 1988, Scandinavian journal of urology and nephrology. Supplementum,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
October 1988, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
April 1983, British medical journal (Clinical research ed.),
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
February 1991, The Urologic clinics of North America,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
November 1976, The British journal of radiology,
H Matzkin, and I Kaver, and O Lewyshon, and D Ayalon, and Z Braf
June 1972, Das Deutsche Gesundheitswesen,
Copied contents to your clipboard!